There are 2789 resources available
231P - Prognosis and efficacy of frontline treatment for HR+ HER2- metastatic breast cancer occurring in gBRCA1/2 carriers
Presenter: Jean-Sebastien Frenel
Session: ePoster Display
302P - Clinical implication of tissue re-biopsy in metastatic breast cancer (MBC) patients: A single centre retrospective analysis
Presenter: Francesca Carlino
Session: ePoster Display
303P - Role of ddPCR in the diagnosis of PIK3CA in breast cancer
Presenter: Zhanet Grudeva-Popova
Session: ePoster Display
304P - Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer
Presenter: Marcus Schmidt
Session: ePoster Display
305P - Real-world health-related quality of life (HRQoL) among HER2-negative (HER2-) advanced breast cancer (ABC) patients in EU3 and US
Presenter: Katie Lewis
Session: ePoster Display
306P - Real-world study of treatments received and treatment satisfaction among HER2- advanced breast cancer (ABC) patients in EU3 and US
Presenter: Katie Lewis
Session: ePoster Display
307P - Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer
Presenter: Eva Blondeaux
Session: ePoster Display
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display
310P - Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study
Presenter: Jose Javier Berenguer-pina
Session: ePoster Display